Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids
Aggressive hepatocellular carcinoma (HCC) overexpressing Angiopoietin-2 (ANG-2) (a protein linked with angiogenesis, proliferation, and epithelial–mesenchymal transition (EMT)), shares 95% of up-regulated genes and a similar poor prognosis with the proliferative subgroup of intrahepatic cholangiocar...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/12/1/87 |
| _version_ | 1797340072358445056 |
|---|---|
| author | Adriana Romanzi Fabiola Milosa Gemma Marcelli Rosina Maria Critelli Simone Lasagni Isabella Gigante Francesco Dituri Filippo Schepis Massimiliano Cadamuro Gianluigi Giannelli Luca Fabris Erica Villa |
| author_facet | Adriana Romanzi Fabiola Milosa Gemma Marcelli Rosina Maria Critelli Simone Lasagni Isabella Gigante Francesco Dituri Filippo Schepis Massimiliano Cadamuro Gianluigi Giannelli Luca Fabris Erica Villa |
| author_sort | Adriana Romanzi |
| collection | DOAJ |
| description | Aggressive hepatocellular carcinoma (HCC) overexpressing Angiopoietin-2 (ANG-2) (a protein linked with angiogenesis, proliferation, and epithelial–mesenchymal transition (EMT)), shares 95% of up-regulated genes and a similar poor prognosis with the proliferative subgroup of intrahepatic cholangiocarcinoma (iCCA). We analyzed the pro-invasive effect of ANG-2 and its regulator vascular endothelial growth factor (VEGF) on HCC and CCA spheroids to uncover posUsible common ways of response. Four cell lines were used: Hep3B and HepG2 (HCC), HuCC-T1 (iCCA), and EGI-1 (extrahepatic CCA). We treated the spheroids with recombinant human (rh) ANG-2 and/or VEGF and then observed the changes at the baseline, after 24 h, and again after 48 h. Proangiogenic stimuli increased migration and invasion capability in HCC- and iCCA-derived spheroids and were associated with a modification in EMT phenotypic markers (a decrease in E-cadherin and an increase in N-cadherin and Vimentin), especially at the migration front. Inhibitors targeting ANG-2 (Trebananib) and the VEGF (Bevacizumab) effectively blocked the migration ability of spheroids that had been stimulated with rh-ANG-2 and rh-VEGF. Overall, our findings highlight the critical role played by ANG-2 and the VEGF in enhancing the ability of HCC- and iCCA-derived spheroids to migrate and invade, which are key processes in cancer progression. |
| first_indexed | 2024-03-08T09:57:39Z |
| format | Article |
| id | doaj.art-3ff6ec006b9c4f7a89266877ad4a75b1 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-08T09:57:39Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-3ff6ec006b9c4f7a89266877ad4a75b12024-01-29T13:47:01ZengMDPI AGBiomedicines2227-90592023-12-011218710.3390/biomedicines12010087Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived SpheroidsAdriana Romanzi0Fabiola Milosa1Gemma Marcelli2Rosina Maria Critelli3Simone Lasagni4Isabella Gigante5Francesco Dituri6Filippo Schepis7Massimiliano Cadamuro8Gianluigi Giannelli9Luca Fabris10Erica Villa11Department of Biomedical, Metabolic and Neural Sciences, Clinical and Experimental Medicine Program, University of Modena and Reggio Emilia, 41125 Modena, ItalyChimomo Department, Gastroenterology Unit, University of Modena and Reggio Emilia, 41125 Modena, ItalyChimomo Department, Gastroenterology Unit, University of Modena and Reggio Emilia, 41125 Modena, ItalyChimomo Department, Gastroenterology Unit, University of Modena and Reggio Emilia, 41125 Modena, ItalyDepartment of Biomedical, Metabolic and Neural Sciences, Clinical and Experimental Medicine Program, University of Modena and Reggio Emilia, 41125 Modena, ItalyNational Institute of Gastroenterology IRCCS “Saverio de Bellis”, Research Hospital, 70013 Castellana Grotte, ItalyNational Institute of Gastroenterology IRCCS “Saverio de Bellis”, Research Hospital, 70013 Castellana Grotte, ItalyChimomo Department, Gastroenterology Unit, University of Modena and Reggio Emilia, 41125 Modena, ItalyDepartment of Molecular Medicine, School of Medicine, University of Padua, 35121 Padua, ItalyNational Institute of Gastroenterology IRCCS “Saverio de Bellis”, Research Hospital, 70013 Castellana Grotte, ItalyDepartment of Molecular Medicine, School of Medicine, University of Padua, 35121 Padua, ItalyChimomo Department, Gastroenterology Unit, University of Modena and Reggio Emilia, 41125 Modena, ItalyAggressive hepatocellular carcinoma (HCC) overexpressing Angiopoietin-2 (ANG-2) (a protein linked with angiogenesis, proliferation, and epithelial–mesenchymal transition (EMT)), shares 95% of up-regulated genes and a similar poor prognosis with the proliferative subgroup of intrahepatic cholangiocarcinoma (iCCA). We analyzed the pro-invasive effect of ANG-2 and its regulator vascular endothelial growth factor (VEGF) on HCC and CCA spheroids to uncover posUsible common ways of response. Four cell lines were used: Hep3B and HepG2 (HCC), HuCC-T1 (iCCA), and EGI-1 (extrahepatic CCA). We treated the spheroids with recombinant human (rh) ANG-2 and/or VEGF and then observed the changes at the baseline, after 24 h, and again after 48 h. Proangiogenic stimuli increased migration and invasion capability in HCC- and iCCA-derived spheroids and were associated with a modification in EMT phenotypic markers (a decrease in E-cadherin and an increase in N-cadherin and Vimentin), especially at the migration front. Inhibitors targeting ANG-2 (Trebananib) and the VEGF (Bevacizumab) effectively blocked the migration ability of spheroids that had been stimulated with rh-ANG-2 and rh-VEGF. Overall, our findings highlight the critical role played by ANG-2 and the VEGF in enhancing the ability of HCC- and iCCA-derived spheroids to migrate and invade, which are key processes in cancer progression.https://www.mdpi.com/2227-9059/12/1/87proangiogenic factorsVEGFAngiopoietin-23D cancer modelmigrationinvasiveness |
| spellingShingle | Adriana Romanzi Fabiola Milosa Gemma Marcelli Rosina Maria Critelli Simone Lasagni Isabella Gigante Francesco Dituri Filippo Schepis Massimiliano Cadamuro Gianluigi Giannelli Luca Fabris Erica Villa Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids Biomedicines proangiogenic factors VEGF Angiopoietin-2 3D cancer model migration invasiveness |
| title | Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids |
| title_full | Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids |
| title_fullStr | Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids |
| title_full_unstemmed | Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids |
| title_short | Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids |
| title_sort | angiopoietin 2 and the vascular endothelial growth factor promote migration and invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma derived spheroids |
| topic | proangiogenic factors VEGF Angiopoietin-2 3D cancer model migration invasiveness |
| url | https://www.mdpi.com/2227-9059/12/1/87 |
| work_keys_str_mv | AT adrianaromanzi angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT fabiolamilosa angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT gemmamarcelli angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT rosinamariacritelli angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT simonelasagni angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT isabellagigante angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT francescodituri angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT filipposchepis angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT massimilianocadamuro angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT gianluigigiannelli angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT lucafabris angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids AT ericavilla angiopoietin2andthevascularendothelialgrowthfactorpromotemigrationandinvasioninhepatocellularcarcinomaandintrahepaticcholangiocarcinomaderivedspheroids |